Following a stroke, MCP-1−/−mice show enhanced blood-brain barrier integrity and decreased production of inflammatory cytokines, whereas IL-1R1−/−mice show improved functional recovery and lower neuroinflammation. This evidence concerns the gene CCL2 and stroke disorder.